Clinical Trials Logo

Clinical Trial Summary

Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in developed countries . An artificial intelligence-based tool could help physicians refine their diagnosis


Clinical Trial Description

Ear infections in children are very common, particularly acute otitis media (AOM) which represents the first reason for visiting physicians and for antibiotic prescription in children in developed countries. However, the diagnosis is not easy because of the narrowness of the ear canal, the discomfort of the child during the otoscopic exam. Moreover, the accuracy of the AOM diagnosis depends on the subjectivity of the physician mostly. This can result in an misdiagnosis and inappropriate treatment with, as a result, the emergence of multi-resistant germ. Artificial intelligence (AI) in medicine is booming and has already proven its worth in terms of prevention, monitoring and diagnosis. I-Nside, an app based on Artificial Intelligence is able to make automatic diagnosis of many ear pathologies, after capturing picture of any eardrum using an otoendoscope fixed on a connected smartphone (SmartScope®). Therefore, the investigators aim to assess the accuracy of AOM diagnosis the existing app, by comparing the inter-rater agreement between the diagnosis made by a senior physician using a traditional otoscope (considered as "gold standard" ) and the one made by a junior physician using the app ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04752891
Study type Interventional
Source Fondation Lenval
Contact
Status Completed
Phase N/A
Start date June 10, 2021
Completion date March 16, 2023

See also
  Status Clinical Trial Phase
Completed NCT01244581 - Amoxicillin-clavulanate in Treating Acute Otitis Media Evaluated by Daily Tympanometry Phase 3
Completed NCT05605262 - Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing. Phase 2/Phase 3
Terminated NCT00315003 - TELI COM - Telithromycin in Children With Otitis Media Phase 3